JULPHAR.AD Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: December 06, 2025
Report Source: 2025 3rd Quarter Report
Gulf Pharmaceutical Industries Julphar Co PJSC. Stock Analysis JULPHAR.AD
Gulf Pharmaceutical Industries engages in the manufacture and sale of medicines, injections, and consumer healthcare products. The company is headquartered in Ras Al Khaimah City, Ras Al-Khaimah. The company went IPO on 2002-10-20. The firm is engaged in manufacturing and selling of medicines, drugs and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The Company’s segments include Manufacturing, Planet, Investments. The products of the Company include general medicines, diabetes solutions, cardiovascular care, consumer healthcare products, wound care and dermatology, respiratory and git medicines. The Company’s subsidiaries include mena cool transportation f.z.e., julphar pharmaceuticals p.l.c., julphar ses l.l.c., diabtec l.l.c and others.
Read More Gulf Pharmaceutical Industries Julphar Co PJSC (JULPHAR.AD) Chart
Key Statistics of Gulf Pharmaceutical Industries Julphar Co PJSC (JULPHAR.AD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AED1.07Volume
1.66MP/E Ratio (TTM)
7.2552 Week Range
Market Cap
1.25BAvg. Volume
2.58MDividend Yield
-Financial Metrics & Statements of Gulf Pharmaceutical Industries Julphar Co PJSC (JULPHAR.AD)
FAQ's for Gulf Pharmaceutical Industries Julphar Co PJSC (JULPHAR.AD)
- According to Musaffa’s Shariah screening methodology, Gulf Pharmaceutical Industries Julphar Co PJSC (JULPHAR.AD) is currently classified as HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.